However, some of the boldest opportunities lie ahead in the peptide, oligonucleotide and large molecule modalities. With sustainability as a recognized priority across industries, the ACS Green ...

platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these ...

platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these ...

specifically to reduce the economic and environmental impacts of manufacturing peptides and oligonucleotides," said Dr. Matt Bio, Chief Scientific Officer, Cambrex. "Our new LPPS technology ...

Sept. 16, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC) therapeutics ...

BAAR, Switzerland - (NewMediaWire) - August 8, 2024 - PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today ...